Ferrer, David Mhart M.

HRN: 20-54-89  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/24/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
03/24/2023
03/31/2023
PO
3.2ml
Q8
AGE
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: